/A

Conditions: Keskivaikeaa/vaikeaa atooppista ihottumaa sairastavat 1-3-vuotiaat lapset
MedDRA version: 14.1Level: LLTClassification code 10003641Term: Atopic eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disorders
Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]

Registration Number: EUCTR2012-002412-95-FI

Lead Sponsor: Iho-ja allergiasairaala, HYKS

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Authorised-recruitment may be ongoing or finished

Sex: All

Target Recruitment: 200

Inclusion Criteria

Are the trial subjects under 18? yes
Number of subjects for this age range: 200
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Atooppisen ihottuman tehokkaan hoidon vaikutus allergiseen nuhaan ja/tai astmaan 1-3-vuotiailla lapsilla ;Secondary Objective: ;Primary end point(s):

Secondary Outcome Measures